Hyong Un, MD

Articles

June 27th 2017

Heterogeneity of Nonadherent Buprenorphine Patients: Subgroup Characteristics and Outcomes

Charles Ruetsch, PhD Joseph Tkacz, MS Vijay R. Nadipelli, MS, BPharm Brenna L. Brady, PhD Naoko Ronquest, PhD Hyong Un, MD Joseph Volpicelli, MD, PhD

Patient and treatment heterogeneity were characterized within a sample of nonadherent buprenorphine members; an improved understanding of these factors may optimize patient—treatment matching and intervention efforts.

January 23rd 2014

The Effects of Federal Parity on Substance Use Disorder Treatment

Susan H. Busch, PhD Andrew J. Epstein, PhD Michael O. Harhay, MPH David A. Fiellin, MD Hyong Un, MD Deane Leader Jr, DBA, MBA Colleen L. Barry, PhD, MPP

Federal parity led to an increase in spending on substance use disorder treatment.

November 19th 2013

Opioid Analgesic Treated Chronic Pain Patients at Risk for Problematic Use

Joseph Tkacz, MS Jacqueline Pesa, PhD, MPH Lien Vo, PharmD, MPH Peter G. Kardel, MA Hyong Un, MD Joseph R. Volpicelli, MD, PhD Charles Ruetsch, PhD

A large proportion of opioid analgesic treated chronic pain patients exhibited behaviors indicative of potentially problematic opioid use, which significantly affected healthcare costs.

July 1st 2004

Current Trends for the Management and Treatment of Depression

Hyong Un, MD